AU2001256350A1 - Regulation of human lysostaphin-like protease - Google Patents

Regulation of human lysostaphin-like protease

Info

Publication number
AU2001256350A1
AU2001256350A1 AU2001256350A AU5635001A AU2001256350A1 AU 2001256350 A1 AU2001256350 A1 AU 2001256350A1 AU 2001256350 A AU2001256350 A AU 2001256350A AU 5635001 A AU5635001 A AU 5635001A AU 2001256350 A1 AU2001256350 A1 AU 2001256350A1
Authority
AU
Australia
Prior art keywords
lysostaphin
protease
regulation
human
human lysostaphin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256350A
Inventor
Shyam Ramakrishnan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2001256350A1 publication Critical patent/AU2001256350A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2001256350A 2000-05-12 2001-05-10 Regulation of human lysostaphin-like protease Abandoned AU2001256350A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20390800P 2000-05-12 2000-05-12
US60203908 2000-05-12
PCT/EP2001/005347 WO2001085959A2 (en) 2000-05-12 2001-05-10 Regulation of human lysostaphin-like protease

Publications (1)

Publication Number Publication Date
AU2001256350A1 true AU2001256350A1 (en) 2001-11-20

Family

ID=22755795

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256350A Abandoned AU2001256350A1 (en) 2000-05-12 2001-05-10 Regulation of human lysostaphin-like protease

Country Status (2)

Country Link
AU (1) AU2001256350A1 (en)
WO (1) WO2001085959A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1465990B1 (en) * 2001-12-21 2011-07-13 Biosynexus Incorporated Truncated lysostaphin molecule with enhanced staphylolytic activity
WO2004030524A2 (en) 2002-10-03 2004-04-15 Pr Pharmaceuticals Treatment of autism and similar disorders

Also Published As

Publication number Publication date
WO2001085959A3 (en) 2002-06-20
WO2001085959A2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AU2002224553A1 (en) Human proteases
AU2001278488A1 (en) Regulation of human matriptase-like serine protease
AU8573401A (en) Regulation of human epithin-like serine protease
AU2001281967A1 (en) Regulation of human desc1-like serine protease
AU2001269095A1 (en) Regulation of human caspase-1-like protease
AU2001266089A1 (en) Regulation of human prostasin-like serine protease
AU2002234568A1 (en) Regulation of human serine palmitoyltransferase
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2001256350A1 (en) Regulation of human lysostaphin-like protease
AU2001293718A1 (en) Regulation of human membrane-type serine protease
AU2002231620A1 (en) Regulation of human patched-like protein
AU2002215956A1 (en) Regulation of human pgc-1-like protein
AU2001268967A1 (en) Regulation of human epithin-like serine protease
AU2001281969A1 (en) Regulation of human carboxylesterase-like enzyme
AU2002210525A1 (en) Regulation of human phospholipase-like enzyme
AU2002215942A1 (en) Regulation of human carboxylesterase-like enzyme
AU2001285782A1 (en) Regulation of human phosphodiesterase-like enzyme
AU2002213949A1 (en) Regulation of human serine protease
AU2001279752A1 (en) Regulation of human masp-like serine protease
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002212246A1 (en) Regulation of human serine palmitoyltransferase-like enzyme
AU2001267548A1 (en) Regulation of human napsin-like aspartyl protease
AU2002221781A1 (en) Regulation of human inositolpolyphosphate 5-phosphatase
AU5033101A (en) Regulation of human heparanase-like enzyme